Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Cengiz Karaçin"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background This study aimed to establish risk groups on the basis of CPS-EG scores, independent of pCR status, in triple-negative breast cancer (TNBC) patients receiving neoadjuvant chemotherapy (NACT) to identify the prognostic impact of th
Externí odkaz:
https://doaj.org/article/6f27287556b24ac09fa0b818fc18e00c
Autor:
Bediz Kurt İnci, Pınar Kubilay Tolunay, Şura Öztekin, Ergin Aydemir, İrem Öner, Öztürk Ateş, Cengiz Karaçin
Publikováno v:
Current Oncology, Vol 31, Iss 10, Pp 5722-5729 (2024)
Background: Currently, the combination of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors and endocrine therapy is a first-line treatment for hormone-receptor-positive and HER2-negative metastatic breast cancer. This study aimed to assess the impact
Externí odkaz:
https://doaj.org/article/a433ba64f8604e4fafa1869340c79037
Autor:
Sema Turker, Hayriye Sahinli, Perihan Perkin, Dogan Yazilitas, Nimet Oge Koklu, Goksen Inanc Imamoglu, Cengiz Karacin, Mustafa Altinbas
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 3, Pp 147-148 (2018)
We present a patient with uncommon metastases of lung cancer. The patient has been followed-up for early stage laryngeal carcinoma in the remission and has had dyspeptic complaints as well. A 62-year-old male patient had epigastric complaints for thr
Externí odkaz:
https://doaj.org/article/177ba3bf3527431189e21bc699c36794
Publikováno v:
Український Журнал Нефрології та Діалізу, Iss 3(67) (2020)
To prevent acute or chronic rejection in renal transplant recipients, immunosuppressive treatments are applied. However, immunosuppressive treatments increase the risk of cytomegalovirus (CMV) infection. The aim of this study was to evaluate the diff
Externí odkaz:
https://doaj.org/article/668f4a08f47c4e539417b6c9136cf295
Publikováno v:
Molecular Imaging and Radionuclide Therapy. 32:87-89
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e2684a95381e0e4cd3e5f7f31c70bab
https://doi.org/10.4274/mirt.galenos.2022.53824
https://doi.org/10.4274/mirt.galenos.2022.53824
Publikováno v:
Journal of Oncology Pharmacy Practice. 29:230-232
Introduction Cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors are the new generation drugs that have been started to be used in our clinical practice recently. These drugs have been shown to have better progression-free survival compared to stand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c3ef7e9a566eee0eb3a98fbebeb81c9
https://doi.org/10.1177/10781552221101799
https://doi.org/10.1177/10781552221101799
Autor:
Onur Ergun, Erdem Birgi, Azad Hekimoğlu, Önder Eraslan, Hasan Ali Durmaz, Cengiz Karaçin, Gökşen İnanç İmamoğlu, Tülay Eren, Doğan Yazılıtaş, Baki Hekimoğlu
Publikováno v:
Acta Radiologica. :028418512311756
Background In recent years, many studies have proven that percutaneous thermal ablation is an effective second-line treatment method with low complication rates in early-stage non-small cell lung carcinoma and lung metastases. Radiofrequency ablation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03436ac069a0244cde46a30db9282075
https://doi.org/10.1177/02841851231175657
https://doi.org/10.1177/02841851231175657
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311786
Introduction Acute toxic leukoencephalopathy (ATL) is a rare complication of cancer treatment, with symptoms varying from mild cognitive impairment to coma. Recognition and management of ATL are important because in most cases, the cessation of the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8adeca609c747367ca32f486de80e3a
https://doi.org/10.1177/10781552231178680
https://doi.org/10.1177/10781552231178680
Publikováno v:
Journal of Oncological Sciences. 7:91-97
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::881187edc26fadfb248cd430c7d761db
https://doi.org/10.37047/jos.2021-81821
https://doi.org/10.37047/jos.2021-81821
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311565
Introduction Cyclin-dependent kinase 4/6 inhibitors are new generation drugs that have recently been used in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negativenegative metastatic breast cancer. Recent studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e5a11efeb10f836d068d6d4425031b9
https://doi.org/10.1177/10781552231156521
https://doi.org/10.1177/10781552231156521